Comparisons13 min readUpdated 2026-01-18

    Push Health Semaglutide: Cost vs Dedicated Providers

    Everything you need to know about getting semaglutide through Push Health's marketplace in 2026. We analyze pricing variability, pharmacy quality, provider expertise, and how the marketplace model compares to dedicated semaglutide providers like Trimi.

    Semaglutide Through Push Health: The Marketplace Approach

    Getting semaglutide through Push Health is fundamentally different from getting it through a dedicated provider. Push Health's marketplace connects you with independent providers who each have their own pricing, pharmacy partners, and clinical approaches. This means your semaglutide experience — from cost to quality to delivery — depends on which provider you select rather than being standardized by the platform.

    This marketplace approach can work well if you find the right provider. An experienced, fairly priced provider with a quality pharmacy partner can deliver an excellent semaglutide treatment experience through Push Health. The challenge is that finding this provider requires research, comparison, and sometimes trial and error — effort that dedicated platforms like Trimi eliminate by standardizing every aspect of the GLP-1 treatment experience.

    Semaglutide Pricing: Push Health vs Trimi

    Semaglutide FactorPush HealthTrimi
    Monthly Cost (Total)$150 - $350+ (varies by provider)From $99/mo (all-inclusive)
    Consultation Fee$50 - $200+ (provider sets price)$0 — included
    Pricing ConsistencyHighly variableSame for all patients
    Dose RangeVaries by providerFull titration range
    Pharmacy QualityVaries by provider's partnerAccredited, standardized
    Tirzepatide Also AvailableDepends on providerYes — always available
    Delivery TimeVariable (3-14+ days)5-7 days
    Follow-Up CostsVaries ($0-$150+)$0 — included
    ShippingVariesFree

    Key Takeaway

    Push Health's pricing range is wide because each provider operates independently. Your actual cost depends entirely on your provider choice. Trimi's consistent pricing eliminates this variability.

    Pharmacy Quality Considerations

    One important consideration with Push Health's marketplace model is pharmacy quality variability. Each provider works with their own compounding pharmacy partner, and the quality standards of these pharmacies can differ. Reputable providers partner with pharmacies that are state-licensed, accredited, and follow USP standards for sterile compounding. Less established providers may work with pharmacies that meet minimum requirements but lack additional accreditations.

    When using Push Health, ask your provider specifically about their compounding pharmacy partner. Key questions include whether the pharmacy is accredited by a recognized organization, whether they follow USP Chapter 797 standards for sterile compounding, and whether they have a track record of consistent quality. These questions may feel awkward to ask, but they directly impact the quality and safety of your medication.

    Dedicated platforms like Trimi handle pharmacy vetting at the platform level, ensuring all patients receive medication from accredited pharmacies meeting standardized quality criteria. This removes the burden of pharmacy evaluation from the patient and provides consistent quality assurance across every prescription.

    Provider Expertise for Semaglutide

    Semaglutide prescribing requires more expertise than many patients realize. Proper dose titration minimizes side effects like nausea, appropriate dose escalation maximizes weight loss results, and ongoing monitoring catches potential issues early. The quality of this clinical management directly impacts both your experience and outcomes.

    On Push Health, provider expertise in semaglutide varies widely. Some providers have extensive GLP-1 prescribing experience and offer excellent clinical management. Others may be newer to weight loss prescribing or treat it as a secondary service. The marketplace does not require or guarantee semaglutide-specific expertise, leaving patients to evaluate this on their own.

    Trimi providers work with semaglutide patients exclusively, building deep expertise through daily practice

    Standardized titration protocols ensure consistent, evidence-based dose management across all patients

    Proactive side effect monitoring catches issues before they become treatment-limiting

    Experience with thousands of GLP-1 patients provides pattern recognition that generalists cannot match

    Bottom Line

    Push Health offers a viable path to semaglutide for patients willing to navigate the marketplace and find a quality provider. The potential for competitive pricing and provider flexibility is real. However, the variability in pricing, pharmacy quality, provider expertise, and delivery speed creates uncertainty that most patients prefer to avoid in an ongoing medical treatment.

    For patients who want consistent quality, predictable pricing, and specialized expertise with their semaglutide treatment, Trimi offers a more reliable experience starting at $149 per month all-inclusive. For a full platform comparison, see our Push Health vs Trimi analysis.

    Frequently Asked Questions

    Does Push Health offer semaglutide for weight loss?

    Yes, semaglutide is available through providers on the Push Health marketplace. Individual providers on the platform can prescribe compounded semaglutide for weight loss based on their clinical judgment. However, since Push Health is a marketplace, the availability, pricing, and formulation of semaglutide depends on which provider you select and their pharmacy partnerships.

    How much does semaglutide cost through Push Health?

    Semaglutide pricing through Push Health varies significantly by provider. Consultation fees range from $50 to $200 or more, and medication costs depend on the provider's pharmacy partner and your dosage. Total monthly costs typically range from $150 to $350 or more. Trimi offers compounded semaglutide starting at $149 per month all-inclusive with consistent pricing.

    Is Push Health semaglutide the same quality as other providers?

    The quality of compounded semaglutide depends on the compounding pharmacy, which varies by provider on Push Health. Reputable providers work with accredited pharmacies following USP standards. Less established providers may use pharmacies with varying quality standards. Verifying your provider's pharmacy partner is an important step when using a marketplace model.

    Can I get tirzepatide instead of semaglutide through Push Health?

    Some providers on Push Health offer tirzepatide in addition to or instead of semaglutide. Availability depends on the individual provider's pharmacy partnerships and prescribing practices. Trimi consistently offers both compounded semaglutide and tirzepatide, ensuring access to both GLP-1 medication classes regardless of which patient you are.

    How long does it take to get semaglutide through Push Health?

    Delivery times through Push Health vary by provider and pharmacy partner. Some providers deliver within a week, while others may take two weeks or longer. There is no platform-wide delivery standard. Trimi consistently delivers semaglutide within 5 to 7 days of provider approval, providing more predictable access to medication.

    What semaglutide doses are available through Push Health?

    Available semaglutide doses depend on the individual provider and their pharmacy partner. Most providers offer the standard titration range from starting doses through maintenance levels. However, dose customization and titration guidance vary by provider expertise. Specialized platforms like Trimi offer the full titration range with expert guidance on optimal dosing.

    Is Push Health or Trimi better for semaglutide?

    For most patients, Trimi offers a better semaglutide experience due to consistent pricing, specialized providers, standardized quality, and reliable delivery. Push Health can be viable if you find an excellent individual provider, but the marketplace variability introduces risk and requires more patient effort. See our full comparison for detailed analysis.

    Sources & References

    1. Push Health. Marketplace and provider information. pushhealth.com, 2026.
    2. STEP 1 trial: semaglutide in adults with overweight or obesity (PubMed).
    3. FDA guidance on compounding and the FDA.
    4. Wegovy prescribing information from the FDA.
    5. United States Pharmacopeia. USP Chapter 797: Pharmaceutical Compounding. 2023.
    6. GoodRx. Semaglutide Price Comparison Data. goodrx.com, 2026.
    7. American Telemedicine Association. Telehealth Practice Guidelines. 2025.
    8. National Association of Boards of Pharmacy. Compounding Pharmacy Standards. 2025.

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Trimi is a competitor to Push Health — this article aims to be fair and balanced, but readers should be aware of our perspective when evaluating the information presented.

    What does the published clinical evidence show for compounded semaglutide?

    Peer-reviewed evidence: Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. (Source: STEP 1, NEJM 2021). Trimi offers compounded semaglutide starting at $99/month on the annual plan, dispensed by 503A community sterile compounding pharmacies (VialsRx — Texas pharmacy license #35264 — and GreenwichRx). Results vary by individual; eligibility is determined by a licensed clinician.

    Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. — STEP 1, NEJM 2021
    Approximately 86% of patients on continued semaglutide treatment maintained ≥5% body-weight reduction from baseline through 68 weeks, vs 33% in the placebo-switch arm. — STEP 4, JAMA 2021
    Semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a mean 39.8-month follow-up in adults with overweight/obesity and pre-existing cardiovascular disease without diabetes. — SELECT, NEJM 2023

    Key Takeaways

    • Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. (Source: STEP 1, NEJM 2021)
    • Approximately 86% of patients on continued semaglutide treatment maintained ≥5% body-weight reduction from baseline through 68 weeks, vs 33% in the placebo-switch arm. (Source: STEP 4, JAMA 2021)
    • Semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a mean 39.8-month follow-up in adults with overweight/obesity and pre-existing cardiovascular disease without diabetes. (Source: SELECT, NEJM 2023)
    • Semaglutide is the active pharmaceutical ingredient; it is FDA-approved in the corresponding brand finished products (Wegovy and Ozempic). Trimi's compounded preparation of the same active ingredient is prepared per individual prescription by 503A community sterile compounding pharmacies and is not itself FDA-approved as a drug.
    • Eligibility requires evaluation by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Dose titration over weeks improves tolerability. Severe gastrointestinal symptoms may cause dehydration and increase acute kidney injury risk.
    • This is general information based on the cited evidence, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history, BMI, and comorbidities.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: January 18, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    21 lbs down in 6 weeks! So happy I started with you guys!

    Outcome: 21 lbs lost in 6 weeks

    Robyn Lynn CurtisFacebook
    Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!

    Outcome: Down 12.5 lbs in 2 months

    Sarah MillerFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2032183
    2. Rubino D, Abrahamsson N, Davies M, et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA.Read StudyDOI: 10.1001/jama.2021.3224
    3. Garvey WT, Batterham RL, Bhatta M, et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine.Read StudyDOI: 10.1038/s41591-022-02026-4
    4. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2307563
    5. Marso SP, Bain SC, Consoli A, et al. (2016). Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa1607141
    6. Perkovic V, Tuttle KR, Rossing P, et al. (2024). Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2403347

    Was this article helpful?

    Keep Reading

    Compare Wegovy and compounded semaglutide side by side: pricing, effectiveness, safety, and availability in 2026. Find out which option saves you more without sacrificing quality.

    Mochi Health semaglutide costs $178/month ($79 membership + $99 medication). Compare dosing, delivery, sublingual vs injectable options, and why Trimi delivers equivalent care at $99/month all-in.

    Everything you need to know about getting semaglutide through Lemonaid Health in 2026. We compare their pricing, pharmacy partnerships, and dosing options to dedicated compounded semaglutide providers

    Ozempic vs compounded semaglutide: compare cost, effectiveness, side effects, and availability in 2026. Learn why most patients choose compounded and save thousands.

    Start your GLP-1 journey — from $99/mo

    Get Started